227 related articles for article (PubMed ID: 8825705)
1. Seroepidemiological study of Epstein-Barr virus infection in Bangladesh.
Haque T; Iliadou P; Hossain A; Crawford DH
J Med Virol; 1996 Jan; 48(1):17-21. PubMed ID: 8825705
[TBL] [Abstract][Full Text] [Related]
2. [A comparison of the detection of IgM antibodies against the viral capsid antigen (VCA) of EBV (Epstein-Barr virus) in various groups of patients, using indirect immunofluorescence, indirect ELISA and reverse ELISA. Study of the diagnostic efficacy of the anti-VCA EBV IgM ELISA-VIDITEST kit].
Pumannová M; Rezbová M; Svecová M; Hrbácková H; Novotná M; Ochotná J; Roubalová K
Klin Mikrobiol Infekc Lek; 2004 Aug; 10(4):186-90. PubMed ID: 15328576
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic importance of heterophile antibodies and immunoglobulins IgA, IgE, IgM and low-avidity IgG against Epstein-Barr virus capsid antigen in children.
Votava M; Bartosová D; Krchnáková A; Crhová K; Kubinová L
Acta Virol; 1996 Apr; 40(2):99-101. PubMed ID: 8886119
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of immunoblot-based assay for detecting Epstein-Barr virus viral capsid antibodies].
Altuğlu I; Aksoy A; Zeytinoğlu A; Orman M
Mikrobiyol Bul; 2010 Apr; 44(2):231-6. PubMed ID: 20549957
[TBL] [Abstract][Full Text] [Related]
5. Anti-EBNA-1 (carboxy-half) IgG antibodies as a seroepidemiological marker for Epstein-Barr virus infection.
Nebel-Schickel H; Hinderer W; Saavedra C; Schmutzler R; Horn J; Vornhagen R; Sonneborn HH
Beitr Infusionsther Transfusionsmed; 1994; 32():134-7. PubMed ID: 9422107
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a multiplex fluorescent microsphere immunoassay for the determination of epstein-barr virus serologic status.
Martins TB; Litwin CM; Hill HR
Am J Clin Pathol; 2008 Jan; 129(1):34-41. PubMed ID: 18089487
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of multiple antibodies to Epstein-Barr virus as markers for detecting patients with nasopharyngeal carcinoma.
Liu MY; Chang YL; Ma J; Yang HL; Hsu MM; Chen CJ; Chen JY; Yang CS
J Med Virol; 1997 Jul; 52(3):262-9. PubMed ID: 9210034
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma (NPC).
Liu MT; Yeh CY
Radiat Med; 1998; 16(2):113-7. PubMed ID: 9650898
[TBL] [Abstract][Full Text] [Related]
9. High incidence of elevated antibody titers to Epstein-Barr virus in patients with uveitis.
Touge C; Agawa H; Sairenji T; Inoue Y
Arch Virol; 2006 May; 151(5):895-903. PubMed ID: 16362642
[TBL] [Abstract][Full Text] [Related]
10. Comparison of three different serological techniques for primary diagnosis and monitoring of nasopharyngeal carcinoma in two age groups from Tunisia.
Karray H; Ayadi W; Fki L; Hammami A; Daoud J; Drira MM; Frikha M; Jlidi R; Middeldorp JM
J Med Virol; 2005 Apr; 75(4):593-602. PubMed ID: 15714486
[TBL] [Abstract][Full Text] [Related]
11. [Comparative study of the prevalence of Epstein-Barr virus infections in Iran and Germany].
Alebouyeh M; Peller P; Goetz O; Ameri MA
Monatsschr Kinderheilkd; 1984 Nov; 132(11):850-1. PubMed ID: 6096701
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus-specific antibodies in Epstein-Barr virus-positive and -negative gastric carcinoma cases in Japan.
Shinkura R; Yamamoto N; Koriyama C; Shinmura Y; Eizuru Y; Tokunaga M
J Med Virol; 2000 Apr; 60(4):411-6. PubMed ID: 10686024
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Epstein-Barr virus (EBV) antibody screening of organ donors for allocation of organs to EBV serostatus matched recipients.
Lazda VA
Transplant Proc; 2006 Dec; 38(10):3404-5. PubMed ID: 17175286
[TBL] [Abstract][Full Text] [Related]
14. The serological signs of the Epstein-Barr virus (EBV) activity in the elderly.
Ternák G; Szúcs G; Uj M
Acta Microbiol Immunol Hung; 1997; 44(2):133-40. PubMed ID: 9330661
[TBL] [Abstract][Full Text] [Related]
15. ELISA for the detection of serum and saliva IgA against the BMRFI gene product of Epstein-Barr virus.
Nadala EC; Tan TM; Wong HM; Ting RC
J Med Virol; 1996 Sep; 50(1):93-6. PubMed ID: 8890046
[TBL] [Abstract][Full Text] [Related]
16. Low prevalence of antibody to human herpesvirus-6 (HHV-6) in Kadazans.
Yadav M; Umamaheswari S; Ablashi DV
Southeast Asian J Trop Med Public Health; 1990 Jun; 21(2):259-63. PubMed ID: 2173152
[TBL] [Abstract][Full Text] [Related]
17. Murine gammaherpesvirus 68 serum antibodies in general human population.
Hricová M; Mistríková J
Acta Virol; 2007; 51(4):283-7. PubMed ID: 18197737
[TBL] [Abstract][Full Text] [Related]
18. Sero-epidemiologic study of the Epstein--Barr virus infectivity in a healthy Cuban population.
Gurtsevich V; Le Riverend E; Ruíz R
Neoplasma; 1979; 26(6):677-83. PubMed ID: 232252
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Epstein-Barr virus antibodies, anti-VCA avidity by immunofluorescence and immunoblot assays for assessment of Epstein-Barr virus immunologic state.
Sener AG; Afsar I; Pinar E
J Virol Methods; 2009 Aug; 159(2):300-2. PubMed ID: 19406156
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of immunoglobulin A antibody against Epstein-Barr virus capsid antigen in adult patients with lupus with disease flare: case control studies.
Chen CJ; Lin KH; Lin SC; Tsai WC; Yen JH; Chang SJ; Lu SN; Liu HW
J Rheumatol; 2005 Jan; 32(1):44-7. PubMed ID: 15630723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
